With or without biopsy in coeliac children?—Impact on dietary compliance and quality of life
- 19 July 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (10) , 4253-4258
Abstract
Critics of the ESPGHAN guidelines on CD question the acceptance of the no-biopsy policy by patients and parents against the backdrop of a lifelong diagnosis. The aim of this study was to investigate the impact of the no-biopsy approach on dietary adherence and health-related quality of life (HRQOL). In this retrospective cohort study, patients ≤ 18 years diagnosed with CD between 2007 and 2017 were sent two questionnaires: a dietary interview and a CD-specific HRQOL questionnaire (CDDUX). Included patients were divided into group A (with biopsies 2012) and C (without biopsies >2012). Fisher exact test and ANOVA were used to analyze the impact of the new diagnostic strategy. Forty-seven percent (82/173 patients) consented to participate in the study. Of them, 63% had a biopsy-confirmed diagnosis (40% before 2012 (group A), 23% after 2012 (group B)), and 37% were diagnosed without biopsies (group C). Dietary compliance was similar in all groups (p = 0.67). Group A scored significantly better on the subscale ‘Having CD’ compared to both groups diagnosed after 2012 (p = 0.003). Group A and group C seemed to score better on the total CDDUCX score when compared to group B (86 and 80% versus 61% respectively, p = 0.13). This was also observed within the subscale Diet; Group A and C scored significantly better than group B (62 and 72% versus 39% respectively, p = 0.09). Conclusions: Omitting duodenal biopsies in the diagnostic approach of our CD cohort had no adverse effect on dietary adherence and HRQOL. What Is Known: • Since the publication of the ESPGHAN guideline of 2012, duodenal biopsies are no longer obligatory in the diagnostic approach of CD if IgA-antibodies for transglutaminase 2 are ≥10× ULN, endomysial antibodies are positive in a second blood sample and the patient/family agrees with the no-biopsy approach. • Literature on the effect of the no-biopsy approach on dietary adherence and HRQOL is scarce. What Is New: • Omitting duodenal biopsies does not influence dietary adherence and quality of life. • In our cohort, lower quality of life measured with the CDDUX subscale ‘Having CD’ is more likely to be related to shorter disease duration than to the diagnostic approach.Keywords
This publication has 16 references indexed in Scilit:
- Epidemiology, Presentation, and Diagnosis of Celiac DiseaseGastroenterology, 2021
- Rate, Risk Factors, and Outcomes of Nonadherence in Pediatric Patients With Celiac Disease: A Systematic ReviewClinical Gastroenterology and Hepatology, 2020
- European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020Journal of Pediatric Gastroenterology and Nutrition, 2020
- Assessment of dietary compliance in celiac children using a standardized dietary interviewClinical Nutrition, 2018
- Global Prevalence of Celiac Disease: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2018
- Coeliac diseaseThe Lancet, 2018
- NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten‐related DisordersJournal of Pediatric Gastroenterology and Nutrition, 2016
- In the 21st Century, what is an acceptable response rate?Australian and New Zealand Journal of Public Health, 2012
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- CDDUX: A Disease‐specific Health‐related Quality‐of‐life Questionnaire for Children With Celiac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008